Levodopa Concentration Profile With Stalevo 75/125 mg
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Levodopa Concentration Profile With Stalevo 75/125 mg is a clinical trial[1].
Key Facts
- Levodopa Concentration Profile With Stalevo 75/125 mg is in the country of Finland[2].
- Levodopa Concentration Profile With Stalevo 75/125 mg's instance of is recorded as clinical trial[3].
- Levodopa Concentration Profile With Stalevo 75/125 mg's start time is recorded as +2009-12-31T00:00:00Z[4].
- Levodopa Concentration Profile With Stalevo 75/125 mg's end time is recorded as +2010-02-28T00:00:00Z[5].
- Levodopa Concentration Profile With Stalevo 75/125 mg's main subject is recorded as Parkinson's disease[6].
- Levodopa Concentration Profile With Stalevo 75/125 mg's number of participants is recorded as {'unit': '1', 'amount': '+20'}[7].
- Levodopa Concentration Profile With Stalevo 75/125 mg's title is recorded as Levodopa Concentration Profile After Repeated Doses of Different Stalevo® Strengths With 3.5 Hours Dosing Frequency; an Open, Randomised, Crossover, Levodopa/Carbidopa Controlled Single Centre Study in Healthy Subjects, Two Parallel Groups[8].
- Levodopa Concentration Profile With Stalevo 75/125 mg's short name is recorded as NEWSTA[9].
- Levodopa Concentration Profile With Stalevo 75/125 mg's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Levodopa Concentration Profile With Stalevo 75/125 mg's ClinicalTrials.gov ID is recorded as NCT01070628[11].
- Levodopa Concentration Profile With Stalevo 75/125 mg's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}[12].
- Levodopa Concentration Profile With Stalevo 75/125 mg's research intervention is recorded as levodopa[13].
- Levodopa Concentration Profile With Stalevo 75/125 mg's research intervention is recorded as (S)-(−)-carbidopa monohydrate[14].
- Levodopa Concentration Profile With Stalevo 75/125 mg's research intervention is recorded as entacapone[15].
- Levodopa Concentration Profile With Stalevo 75/125 mg's clinical trial phase is recorded as phase I clinical trial[16].
- Levodopa Concentration Profile With Stalevo 75/125 mg's research subject recruitment status is recorded as completed[17].
- Levodopa Concentration Profile With Stalevo 75/125 mg's study type is recorded as interventional study[18].